LEGAL & GENERAL GROUP PLC – Regeneron Pharmaceuticals, Inc. Transaction History
LEGAL & GENERAL GROUP PLC portfolio value:
$601.37M
portfolio value
LEGAL & GENERAL GROUP PLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -1.17% | -10.30K shares | 79.23M | $688.87 | 872.98K |
Q2 2022 | share | Increase | +9.33% | 75.39K shares | -42.11M | $591.13 | 883.28K |
Q1 2022 | share | Increase | +7.65% | 57.38K shares | 90.28M | $698.42 | 807.89K |
Q4 2021 | share | Decrease | -2.04% | -15.60K shares | 10.32M | $642.51 | 750.50K |
Q3 2021 | share | Increase | +2.83% | 21.06K shares | 47.49M | $605.18 | 766.11K |
Q2 2021 | share | Increase | +5.14% | 36.40K shares | 80.85M | $558.54 | 745.05K |
Q1 2021 | share | Decrease | -2.02% | -14.58K shares | -14.10M | $473.14 | 708.64K |
Q4 2020 | share | Increase | +5.85% | 39.97K shares | -33.07M | $483.11 | 723.22K |
Q3 2020 | share | Decrease | -1.33% | -9.18K shares | -49.34M | $559.78 | 683.24K |
Q2 2020 | share | Increase | +29.55% | 157.92K shares | 171.23M | $623.65 | 692.42K |
Q1 2020 | share | Increase | +2.34% | 12.20K shares | 64.48M | $488.29 | 534.49K |
Q4 2019 | share | Increase | +4.21% | 21.10K shares | 57.08M | $375.48 | 522.29K |
Q3 2019 | share | Increase | +1.48% | 7.31K shares | -15.56M | $277.4 | 501.18K |
Q2 2019 | share | Increase | +3.22% | 15.41K shares | -41.88M | $313 | 493.86K |
Q1 2019 | share | Increase | +24.44% | 93.95K shares | 52.85M | $410.62 | 478.45K |
Q4 2018 | share | Increase | +6.80% | 24.49K shares | -1.84M | $373.5 | 384.5K |
Q3 2018 | share | Increase | +2.50% | 8.79K shares | 24.29M | $404.04 | 360.00K |
Q2 2018 | share | Decrease | -3.77% | -13.76K shares | -4.50M | $344.99 | 351.21K |
Q1 2018 | share | Increase | +0.95% | 3.43K shares | -10.25M | $344.36 | 364.97K |
Q4 2017 | share | Decrease | -2.58% | -9.57K shares | -30.00M | $375.96 | 361.54K |
Q3 2017 | share | Increase | +0.74% | 2.72K shares | -15M | $447.12 | 371.11K |
Q2 2017 | share | Increase | +2.24% | 8.06K shares | 41.3M | $491.14 | 368.38K |
Q1 2017 | share | Increase | +4.68% | 16.11K shares | 13.27M | $387.51 | 360.32K |
Q4 2016 | share | Increase | +0.65% | 2.20K shares | -11.13M | $367.09 | 344.20K |
Q3 2016 | share | Increase | +1.28% | 4.32K shares | 19.56M | $402.02 | 341.99K |
Q2 2016 | share | Increase | +0.47% | 1.59K shares | -3.21M | $349.23 | 337.67K |
Q1 2016 | share | Decrease | -1.67% | -5.70K shares | -64.41M | $360.44 | 336.08K |